P

Perpetual Succour Hospital | Cebu Cancer Institute - Oncology Department

Research site

(Unclaimed)

Location

12th Floor, Our Mother of Perpetual Succour Specialty Center, Cebu City, Cebu, Philippines

Site insights

Top conditions

Top treatments

Pregabalin

Taxane

Tofacitinib

Farletuzumab

Pegcetacoplan

Bevacizumab

PF-00299804

ANX005

Azvudine

Adalimumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiova...

Enrolling

Chronic Kidney Disease

Atherosclerosis Cardiovascular Disease

Drug: Orforglipron

Drug: Placebo

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection...

Enrolling

SARS-CoV-2 Infection

Drug: Azvudine

Drug: Placebo